Long-Term Follow-Up Studies | AVONEX® (interferon beta-1a)
Long-Term Follow-Up Studies | AVONEX® (interferon beta-1a)
Long-Term Follow-Up Studies | AVONEX® (interferon beta-1a)
Long-Term Follow-Up Studies | AVONEX® (interferon beta-1a)
25 Years of Treating MS: Changing the Approach to Patient Care Sponsored Article | Multiple Sclerosis News Today
Managing Common Side Effects of AVONEX® (interferon beta-1a)
Avonex injection: Side effects, use for MS, dosage, and more
ECTRIMS2022 – Long-term Gilenya Reduces Pediatric Relapses | Multiple Sclerosis News Today
Managing Common Side Effects of AVONEX® (interferon beta-1a)
Long-Term Follow-Up Studies | AVONEX® (interferon beta-1a)
Avonex (Interferon Beta-1a) in MS | Uses, Side Effects, and More | Multiple Sclerosis News Today
IJMS | Free Full-Text | Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study
Avonex (interferon beta 1a) | MS Trust
Safety and side effects
Managing Common Side Effects of AVONEX® (interferon beta-1a)
Long-Term Treatments for Multiple Sclerosis | MSAA
IJMS | Free Full-Text | Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study
New Rebif® (interferon beta-1a) Data at ECTRIMS Highlights the Importance of Disability and Imaging Predictors for Long Term Ou
SELF-INJECTED MEDICATIONS
Managing Common Side Effects of AVONEX® (interferon beta-1a)
Beta interferons
Avonex® PEN Satisfaction and Patients Experience Clinical Trial | Canadian Journal of Neurological Sciences | Cambridge Core
Avonex Injection: Side Effects, Use for MS, Dosage, and More
